Rating History for Madrigal Pharmaceuticals (MDGL) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/4/2026 | Andy Chen | Upgrade | Outperform (Peerperform) |
605.00 (N/A) |
482.00 (538.71) |
11.77% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
